ISMPP Highlights
“In The Know” – Key Updates in Medical Communications
“In The Know” highlights various updates in medical publications and communications: New CHEERS 2022 Guidance, Preprints in ICMJE Recommendations, Carbon Costs of In-Person vs Virtual Medical Conferences, Readability and Format of PLS, AI-Assisted Tools in Scholarly Communications, Peer Review Congress in September 2022…
GPP4 – The Latest Update as Interest Grows
Excitement is building as the fourth iteration of the Good Publication Practice (also known as GPP4) guidance nears completion. At the 2022 European Meeting of ISMPP in late January, Dan Bridges (CEO, Nucleus Global) of the GPP4 Steering Committee presented information on the team’s progress. Watch the video to view this GPP4 update…
Building an ISMPP Educational Plan to Move Us All Forward
ISMPP consistently provides foundational educational resources for medical publication and communication professionals worldwide. To ensure alignment with the future educational needs of our members and to inform development of a longer-term, dynamic educational plan, the ISMPP Education Task Force launched a needs assessment survey in Q1 2021…
Message from Our Leadership
Robert J. Matheis
ISMPP President and CEO
News and Trends
A Snapshot into Medical Affairs
What does a Medical Affairs team look like at a pharmaceutical/biotechnology company? Is it like a bag of M&M’S® with similar functions, or is it unique from company to company, like a fingerprint? We conducted a survey of ISMPP members in March 2021, that provides insights into what comprises Medical Affairs at pharmaceutical/biotechnology companies…
A Company’s Approach to Developing Publication Plain Language Summaries
Scientific publications tend to be written with a specialized audience in mind… Plain language summaries (PLS) of publications represent a way to communicate research more broadly using everyday language. Pfizer recognized this, and in early 2020 implemented a company-wide process for developing PLS…
Pressure in a Pandemic: Lessons for Communicating Scientific Research
Since the global pandemic started, there has been immense pressure to address the threat imposed by COVID-19. Researchers have risen to the challenge and, by working collaboratively, developed effective vaccines and identified some treatment options over an impressively short timescale…
What Would You Do?
In our role as medical publication professionals, we may occasionally encounter situations in which it is not obvious how to ensure good publication practice. Have you ever wished you could consult the ISMPP membership for guidance when these situations arise? Here’s your opportunity!
What Would You Do? is a section of The MAP that presents case scenarios as an educational tool for medical publication professionals. The section provides a case scenario to ponder, and readers are invited to participate in a poll by selecting one of the listed solutions. Readers can also submit their thoughts on the scenario anonymously. The poll results, plus educational insights, are posted in a later issue for readers to digest.
POLL: Journal Questions Medical Writer Acknowledgement & Funding
The lead author of a meta-analysis manuscript received a rejection notice from a journal that stated “…although the topic may be of interest to the readership, the Editors are concerned about the perception of bias given the statement of funding support from the sponsor and the participation of a paid, professional medical writer.” The lead author has emailed all authors, sponsor, and medical communications agency suggesting that the manuscript be revised by the authors alone so that acknowledgement of the medical writer and funding from the sponsor to support medical writing can be removed…
ISMPP (pronounced IzMap) is the only nonprofit organization founded by medical publication professionals for medical publication professionals